Tempest Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Brisbane, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Tempest Therapeutics, Inc. has filed 1,035 SEC EDGAR filings since 09 Apr 2012

SEC filing history

Showing 76-78 of 78 matching filings.

Per page
25
Current page
4
SC 13G/A File 005-87213

OVASCIENCE, INC. SCHEDULE 13G, AMENDMENT 1

Filing date
06 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87213

SC 13G filing

Filing date
14 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87213

OVASCIENCE, INC. SCHEDULE 13G STATEMENT

Filing date
12 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .